259729-95-8

Basic information

• Product Name: (S)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine L(+)-tartrate
• Synonyms: (S)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine L(+)-tartrate
• CAS NO: 259729-95-8
• Molecular Weight: 401.887
• Mol File: 259729-95-8.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (S)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine L(+)-tartrate(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine L(+)-tartrate(259729-95-8)
• EPA Substance Registry System: (S)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine L(+)-tartrate(259729-95-8)

Safety Data

• Hazardous Substances Data: 259729-95-8(Hazardous Substances Data)

Upstream product

• 14377-68-5 1-phenylcyclobutanecarbonitrile 
• 87-69-4 L-Tartaric acid 
• 106650-56-0 didesmethylsibutramine 
• 229639-57-0 (S)-(-)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine 

Downstream Products

• 229639-57-0 (S)-(-)-1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine 

Relevant articles and documents

PHENYLCYCLOBUTYLAMIDE DERIVATIVES AND THEIR STEREOISOMERS, THE PREPARATION PROCESSES AND USES THEREOF

Phenylcyclobutylamide derivatives and their optical isomers, the preparing processes and the uses thereof, which includes the compounds of formula (I), their pure stereoisomers and their pharmaceutically acceptable salts. In formula (I), R is H, formacyl,

USE OF (S)-DIDESMETHYLSIBUTRAMINEFOR TREATING, PREVENTING AND MANAGING A SLEEP DISORDER

This invention relates, in part, to methods of treating, preventing and/or managing a sleep disorder using enantiomerically pure (S)-didesmethylsibutramine, or a pharmaceutically acceptable salt, hydrate, solvate, clathrate or prodrug thereof. Specific me